Back to search results
Not yet recruiting

Crohn's Disease

A Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease

AMAM | {{ defaultRegistry.registryAnchorText }} NCT03926130 {{ currentLocaleObject.registryAnchorText }}

Study Purpose

The reason for this study is to see if the study drug mirikizumab is safe and effective in participants with moderately to severely active Crohn's disease.

Time Commitment

The study will last about 72 weeks and may include up to 19 visits.

Key Participation Requirements Tool Tip Icon

All clinical trials have rules about who can participate. This section outlines some of those rules. Please contact a study center to discuss the full set of criteria

Gender

Male Female

Age

18 years
80 years

-Participants must have a diagnosis of Crohn's Disease (CD) for at least 3 months prior to baseline

-Participants must have a confirmed diagnosis of moderate to severe CD

-Participants must have demonstrated intolerance, loss of response or inadequate response to conventional or to biologic therapy for CD

-Participants must, if female, meet the contraception recommendations

-Participants must not have a current diagnosis of ulcerative colitis, inflammatory bowel disease-unclassified (IBD-U) (formerly known as indeterminate colitis), abdominal or perianal abscess or short bowel syndrome

-Participants must not have a stoma or ostomy

-Participants must not have had a bowel resection within 6 months, or any kind of intra-abdominal or extra abdominal surgery within 3 months of baseline

-Participants must not have ever received any monoclonal antibodies binding IL-23

Where to Participate

Where to Participate

Invalid Postal Code.
Please re-enter postal code.

{{sites.getPageStartCount()}} - {{sites.getPageEndCount()}} of {{sites.totalCount}} Results

0 of {{sites.totalCount}} Results

Distance Location Status
{{site.getDistance() | number:0}} {{convertUnit("imperial", "mile") | translate}} {{convertUnit("imperial", "miles") | translate}}
,
{{site.siteStatus | translate}}
Closest Location to Participate
{{site.getDistance() | number:0}} {{convertUnit("imperial", "mile") | translate}} {{convertUnit("imperial", "miles") | translate}}
,
{{site.siteStatus | translate}}
Other Location(s) to Participate
{{site.getDistance() | number:0}} {{convertUnit("imperial", "mile") | translate}} {{convertUnit("imperial", "miles") | translate}}
,
{{site.siteStatus | translate}}

To improve your experience on Lilly TrialGuide, please use the latest version of Chrome, Firefox, Safari, or Internet Explorer, with Java Script enabled.
This website is not optimized for your browser, as configured.